Patricia Lizarraga knows she needs to increase the assets of her firm’s $3.9 million Hypatia Women CEO ETF to give it any chance of hitting institutional investors’ radar screens. And she’s also sure ...

Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...